e-learning
resources
Berlin 2001
Monday 24.09.2001
From noninvasive to invasive treatment strategies for different degrees of acute respiratory failure
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Two cases of clinically diagnosed ARDS, first treated as acute atypical pneumonia, caused by noninfectious acute mitral regurgitation
B. Wartner, T. Mueller, M. Pfeifer, G. Riegger (Regensburg, Germany)
Source:
Annual Congress 2001 - From noninvasive to invasive treatment strategies for different degrees of acute respiratory failure
Session:
From noninvasive to invasive treatment strategies for different degrees of acute respiratory failure
Session type:
Thematic Poster Session
Number:
1635
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Wartner, T. Mueller, M. Pfeifer, G. Riegger (Regensburg, Germany). Two cases of clinically diagnosed ARDS, first treated as acute atypical pneumonia, caused by noninfectious acute mitral regurgitation. Eur Respir J 2001; 16: Suppl. 31, 1635
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded)
Source: Eur Respir Mon; 2008: 41: 60–71
Year: 2008
Pulmonary function in patients recovering from severe acute respiratory syndrome (SARS)
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004
Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia
Source: Eur Respir J 2013; 41: 402-409
Year: 2013
Acute heart failure and fatal arrythmia in severe pneumonias, caused by influenza A(H1N1pdm09) virus
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome
Source: Eur Respir J 2004; 23: 802-804
Year: 2004
The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients?
Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients
Year: 2015
Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005
Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Fatal acute exacerbation of idiopathic pulmonary fibrosis: report of 4 cases
Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Year: 2007
Prognosis after severe chronic obstructive pulmonary disease exacerbation treated with non invasive ventilation
Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure
Year: 2009
Evaluation of incidental exacerbation of interstitial pneumonia in patients with non-respiratory diseases
Source: International Congress 2017 – Rare diseases
Year: 2017
Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients
Source: Eur Respir J 2012; 39: 855-861
Year: 2012
Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy
Source: Eur Respir J, 54 (1) 1802442; 10.1183/13993003.02442-2018
Year: 2019
Cryptogenic organizing pneumonia (COP) as a cause of severe acute respiratory failure
Source: Eur Respir J 2004; 24: Suppl. 48, 507s
Year: 2004
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007
Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept